| Literature DB >> 31226797 |
Luca Frattaruolo1, Gabriele Carullo2, Matteo Brindisi3, Sarah Mazzotta4,5, Luca Bellissimo6, Vittoria Rago7, Rosita Curcio8, Vincenza Dolce9, Francesca Aiello10, Anna Rita Cappello11.
Abstract
Inflammation represents an adaptive response generated by injuries or harmful stimuli. Natural remedies represent an interesting alternative to traditional therapies, involving several biochemical pathways. Besides, the valorization of agrochemical wastes nowadays seems to be a feasible way to reduce the health spending and improve the accessibility at bioactive natural compounds. In this context, the chemical composition of three Glycyrrhiza glabra L. (licorice) leaf extracts, obtained through maceration or ultrasound-assisted method (fresh and dried leaves) was investigated. A guided fractionation obtained three main components: pinocembrin, glabranin and licoflavanone. All the extracts showed similar antioxidant properties, evaluated by 2,2'-diphenyl-1-picrylhydrazyl (DPPH) or 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) Diammonium Salt (ABTS) assay, while, among the isolated compounds, licoflavanone exhibited the best antioxidant activity. The anti-inflammatory activity of the extracts and the purified compounds was investigated in lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophages. Extract C and licoflavanone showed a good anti-inflammatory activity without affecting cell viability, as they decreased nitrite levels even when used at 12.5 μg/mL (p < 0.005) and 50 μM concentration (p < 0.001), respectively. Interestingly, licoflavanone markedly decreased pro-inflammatory cytokines and cyclooxygenase 2/inducible nitric oxide synthase (COX-2/iNOS) expression levels (p < 0.001). A modulation of nuclear factor kappa B/mitogen-activated protein kinases (NF-kB/MAPK) pathway underlay such behavior, highlighting the potential of this natural compound as a new scaffold in anti-inflammatory drug research.Entities:
Keywords: Glycyrrhiza glabra; NF-kB/MAPK pathway; anti-inflammatory activity; antioxidant activity; licoflavanone; pinocembrin
Year: 2019 PMID: 31226797 PMCID: PMC6616548 DOI: 10.3390/antiox8060186
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Representative extraction procedures.
qPCR primers sequences.
| Primer Name | Sequence (5′-3′) |
|---|---|
| iNOS-Fw | CGAAACGCTTCACTTCCAA |
| iNOS-Rv | TGAGCCTATATTGCTGTGGCT |
| COX2-Fw | AACCGCATTGCCTCTGAAT |
| COX2-Rv | CATGTTCCAGGAGGATGGAG |
| TNFa-Fw | CAGGCGGTGCCTATGTCTC |
| TNFa –Rv | CGATCACCCCGAAGTTCAGTAG |
| IL1b-Fw | GAAATGCCACCTTTTGACAGTG |
| IL1b-Rv | TGGATGCTCTCATCAGGACAG |
| IL6-Fw | CTGCAAGAGACTTCCATCCAG |
| IL6-Rv | AGTGGTATAGACAGGTCTGTTGG |
| GAPDH-Fw | ACCACAGTCCATGCCATCAC |
| GAPDH-Rv | TCCACCACCCTGTTGCTGTA |
Figure 2Gas chromatography/mass spectrometry (GC-MS) chromatograms of the phytocomplexes from Glycyrrhiza glabra L. leaves and chemical structure of isolated compounds.
Figure 3Antioxidant profile of G. glabra L. leaf extracts and isolated flavanones.
Antioxidant activity (IC50 values) of G. glabra L. leaf extracts and isolated flavanones.
| IC50 ± SD (µg/mL) | IC50 ± SD (µM) | |||||
|---|---|---|---|---|---|---|
| Extract A | Extract B | Extract C | M2 | M3 | M4 | |
|
| 13.49 ± 1.91 | 18.05 ± 4.3 | 15.5 ± 2.5 | n.c. | n.c. | n.c. |
|
| 6.76 ± 0.78 | 6.1 ± 1.04 | 5.88 ± 0.83 | 166.3 ± 47.7 | n.c. | 59.55 ± 21.9 |
n.c.: not calculable.
Total phenolic content estimation of G. glabra L. leaf extracts.
| Extract A | Extract B | Extract C | |
|---|---|---|---|
| 154.03 ± 10.03 | 190.37 ± 13.95 | 165.63 ± 9.21 |
Extract A: extract from fresh leaves macerated with methanol; Extract B: extract from fresh leaves after ultrasound assisted extraction with ethanol; Extract C: extract from dried leaves after ultrasound assisted extraction with ethanol.
Figure 4G. glabra L. leaf extracts (extracts A, B and C) and the isolated flavanones (M2, M3, M4) modulate nitric oxide (NO) production. Cell viability and nitrites production assessments after treatment of LPS-stimulated RAW 264.7 cell line with different concentration of extracts or isolated compounds for 24 h. MTT assay results are expressed as percentage of cell viability versus control; Griess assay results are expressed as percentage of nitrites production versus control. Values represent mean ± S.D. of three independent experiments, each one performed with triplicate samples. * p < 0.05; ** p < 0.01; *** p < 0.005; **** p < 0.001.
Nitrites production inhibitory activity (IC50 values).
| IC50 ± SD (µg/mL) | IC50 ± SD (µM) | ||||
|---|---|---|---|---|---|
| Extract A | Extract B | Extract C | M2 | M3 | M4 |
| 17.72 ± 3.79 | 11.73 ± 2.09 | 16.11 ± 1.5 | 60.49 ± 26.78 | 206.5 ± 44.89 | 37.68 ± 6.67 |
Figure 5G. glabra L. leaf extract and licoflavanone inhibit NF-kB nuclear translocation. Immuno-fluorescent localization of NF-kB in RAW 264.7 cells treated for 1 h with DMSO (A), 1 µg/mL LPS + DMSO (B), 1 µg/mL LPS + 25 µg/mL Extract C (C), 1 µg/mL LPS + licoflavanone at IC50 value (D). Scale bar: 25 µm.
Figure 6Licoflavanone (M4), as well as the phytocomplex from which it was isolated (extract C), disrupts mitogen-activated protein kinases (MAPK)/NF-kB pathway and modulates pro-inflammatory cytokines in RAW 264.7 cells. (A) Effects of extract C and M4 (both used at their IC50 values) on inducible nitroxide synthase (iNOS) and cyclooxygenase 2 (COX2) mRNA levels. (B) Immunoblotting analysis of phosphorylated MAPKs (p-p38, p-JNK and p-ERK) and relative quantification of expression levels. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as loading control (C) Effects of treatments on pro-inflammatory cytokines (Tumor Necrosis Factor alpha (TNFα), Interleukin-1 beta (IL 1β) and Interleukin-6 (IL 6)) mRNA levels. Treatment conditions for the different experiments are reported in the Methods (Section 2.11 and Section 2.12). Values represent mean ± S.D. of three independent experiments, each one performed with triplicate samples. * p < 0.05; ** p < 0.01; **** p < 0.001.